Nicolas. Bonhoure, et.al., Loss of the RNA polymerase III repressor MAF1 confers obesity resistance., Genes & development, 2015, 29

http://rdf.ncbi.nlm.nih.gov/pubmed/25934505

Nicolas. Bonhoure, et.al., Loss of the RNA polymerase III repressor MAF1 confers obesity resistance., Genes & development, 2015, 29

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Maf1<em1Lnh>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5661490

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal amino acid level_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0005332IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• increased white fat cell number_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0009130IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased food intake_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0011940IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased lean body mass_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0003961IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• increased insulin sensitivity_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0002891IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased percent body fat/body weight_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0005459IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• slow postnatal weight gain_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0008489IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased body length_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0001258IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased susceptibility to diet-induced obesity_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0005659IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• extended life span_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0001661IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• increased energy expenditure_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0004889IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased epididymal fat pad weight_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0009289IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• abnormal homeostasis_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0001764IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• abnormal lipid homeostasis_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0002118IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• reduced fertility_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0001921IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased susceptibility to hepatic steatosis_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0002310IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• increased hormone-sensitive lipase activity_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0011590IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• postnatal growth retardation_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0001732IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• increased proline level_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0020237IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased omental fat pad weight_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0010046IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased subcutaneous adipose tissue amount_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0008844IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased circulating phospholipid level_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0003981IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• decreased white fat cell size_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0009133IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• increased dopamine level_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0001906IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh
• increased oxygen consumption_Maf1<tm1.1Lnh>/Maf1<tm1.1Lnh>
  http://metadb.riken.jp/0005289IC57BL6Maf1tm11LnhMaf1tm11LnhMaf1tm11Lnh

class

http://purl.org/net/cito/citesAsAuthority

• Maf1<em1Lnh>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5661490